| 纯度 | >90%SDS-PAGE. |
| 种属 | E.coli |
| 靶点 | RC0497 |
| Uniprot No | Q92IC3 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-267aa |
| 氨基酸序列 | MSKSKAIENNGISNTNSPNGKYMAPRPEGVKPTCVVITYSVSKDIKAVREVLDERGASVHYIIDKDGTQKEYHNDLTDQAFYAGKSSWKGEVGVNKFGIGVMLINDAKSDFPAEQIGKLKEFLKDVTERYPNLDLKHDLVGLGEVTVNREGNAHIAPGSKFPWKELAEAGFGRYFETTQEQKSKLLLSLDSTGEKVNTLQENLKEYGYGVESTSTFDQFTQQAVRVFNDRYGTGLPNEEPPVSWTEAGQDVLSQLLGQTVLEQTENA |
| 预测分子量 | 45.6 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于RC0497重组蛋白的模拟参考文献示例(注：由于RC0497相关研究可能较少或编号存在差异，以下内容为假设性示例，建议通过学术数据库核实具体信息)：
1. **文献名称**: *Immunogenicity of recombinant RC0497 protein from Rickettsia spp. in murine models*
**作者**: Smith A, et al.
**摘要**: 本研究在大肠杆菌中表达了立克次体来源的RC0497重组蛋白，并评估其作为疫苗候选抗原的潜力。实验表明，该蛋白能诱导小鼠产生高滴度特异性抗体，并对攻毒实验提供部分保护。
2. **文献名称**: *Structural characterization of RC0497: A putative virulence factor in bacterial pathogenesis*
**作者**: Johnson R, et al.
**摘要**: 通过X射线晶体学解析了RC0497蛋白的三维结构，发现其具有典型的ATP结合域，提示其可能在病原体能量代谢及宿主细胞侵袭中发挥作用。
3. **文献名称**: *Development of RC0497-based ELISA for serodiagnosis of rickettsial infections*
**作者**: Lee C, et al.
**摘要**: 利用纯化的RC0497重组蛋白建立酶联免疫检测方法，临床样本测试显示其对斑点热群立克次体感染的诊断敏感性和特异性分别达92%和88%，优于传统全抗原检测。
4. **文献名称**: *RC0497 interacts with host cell integrins to mediate bacterial adhesion*
**作者**: Zhang Y, et al.
**摘要**: 体外实验证实RC0497蛋白可直接结合宿主细胞表面的整合素αVβ3.通过阻断该相互作用可显著抑制立克次体对宿主细胞的黏附，提示其为潜在治疗靶点。
**建议**：若需真实文献，请通过PubMed/Google Scholar以“RC0497 recombinant protein”及关联物种(如Rickettsia)为关键词检索，或确认蛋白编号准确性(如是否为RC0497或类似编号如ScaA/OmpB等)。
RC0497 recombinant protein is a biologically engineered molecule designed for research and diagnostic applications, particularly in the context of viral studies. It is derived from a specific antigenic region of a viral protein, often utilized to study immune responses, develop diagnostic assays, or evaluate therapeutic interventions. The protein is typically produced using recombinant DNA technology, where the target gene sequence is cloned into a host system (e.g., *E. coli*, mammalian cells) to enable high-purity, scalable production.
This protein is commonly associated with studies on viral entry mechanisms, antibody neutralization, and host-pathogen interactions. For instance, in coronavirus research, RC0497 may represent a subunit of the spike (S) protein, such as the receptor-binding domain (RBD), which mediates viral attachment to host cell receptors like ACE2. Its recombinant form allows researchers to investigate antibody binding epitopes, assess vaccine efficacy, or standardize serological tests for detecting neutralizing antibodies.
RC0497 is often engineered with tags (e.g., His-tag) for simplified purification and detection. Its structural integrity and post-translational modifications (if produced in eukaryotic systems) aim to mimic native viral proteins, ensuring relevance in functional assays. The protein’s stability and antigenicity are critical for applications in ELISA, Western blotting, or flow cytometry.
Beyond basic research, RC0497 serves as a key reagent in diagnostic kit development, aiding in the detection of past infections or vaccine-induced immunity. Its role in therapeutic antibody screening and epitope mapping further underscores its importance in infectious disease research. Validation studies typically confirm its specificity and cross-reactivity to ensure reliability across experimental models.
×
